These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24262869)

  • 41. Regional cortical thickness and cognitive functions in non-demented Parkinson's disease patients: a pilot study.
    Pellicano C; Assogna F; Piras F; Caltagirone C; Pontieri FE; Spalletta G
    Eur J Neurol; 2012 Jan; 19(1):172-5. PubMed ID: 21771199
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Progression of cortical thinning in early Parkinson's disease.
    Ibarretxe-Bilbao N; Junque C; Segura B; Baggio HC; Marti MJ; Valldeoriola F; Bargallo N; Tolosa E
    Mov Disord; 2012 Dec; 27(14):1746-53. PubMed ID: 23124622
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Color discrimination deficits in Parkinson's disease are related to cognitive impairment and white-matter alterations.
    Bertrand JA; Bedetti C; Postuma RB; Monchi O; Génier Marchand D; Jubault T; Gagnon JF
    Mov Disord; 2012 Dec; 27(14):1781-8. PubMed ID: 23147270
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cognitive reserve proxies relate to gray matter loss in cognitively healthy elderly with abnormal cerebrospinal fluid amyloid-β levels.
    Arenaza-Urquijo EM; Molinuevo JL; Sala-Llonch R; Solé-Padullés C; Balasa M; Bosch B; Olives J; Antonell A; Lladó A; Sánchez-Valle R; Rami L; Bartrés-Faz D
    J Alzheimers Dis; 2013; 35(4):715-26. PubMed ID: 23481686
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuroanatomical correlates of depression and apathy in Parkinson's disease: magnetic resonance imaging studies.
    Kostić VS; Filippi M
    J Neurol Sci; 2011 Nov; 310(1-2):61-3. PubMed ID: 21684552
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cognitive impairment and gray/white matter volume abnormalities in pediatric patients with Turner syndrome presenting with various karyotypes.
    Zhao Q; Zhang Z; Xie S; Pan H; Zhang J; Gong G; Cui Z
    J Pediatr Endocrinol Metab; 2013; 26(11-12):1111-21. PubMed ID: 23846137
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural correlates of facial emotion recognition deficits in Parkinson's disease patients.
    Baggio HC; Segura B; Ibarretxe-Bilbao N; Valldeoriola F; Marti MJ; Compta Y; Tolosa E; Junqué C
    Neuropsychologia; 2012 Jul; 50(8):2121-8. PubMed ID: 22640663
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Olfactory-related cortical atrophy is associated with olfactory dysfunction in Parkinson's disease.
    Lee EY; Eslinger PJ; Du G; Kong L; Lewis MM; Huang X
    Mov Disord; 2014 Aug; 29(9):1205-8. PubMed ID: 24482154
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical and cognitive correlations of regional gray matter atrophy in progressive supranuclear palsy.
    Giordano A; Tessitore A; Corbo D; Cirillo G; de Micco R; Russo A; Liguori S; Cirillo M; Esposito F; Tedeschi G
    Parkinsonism Relat Disord; 2013 Jun; 19(6):590-4. PubMed ID: 23477861
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlations between gray matter reductions and cognitive deficits in dementia with Lewy Bodies and Parkinson's disease with dementia.
    Sanchez-Castaneda C; Rene R; Ramirez-Ruiz B; Campdelacreu J; Gascon J; Falcon C; Calopa M; Jauma S; Juncadella M; Junque C
    Mov Disord; 2009 Sep; 24(12):1740-6. PubMed ID: 19569130
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contribution of four lifelong factors of cognitive reserve on late cognition in normal aging and Parkinson's disease.
    Rouillard M; Audiffren M; Albinet C; Ali Bahri M; Garraux G; Collette F
    J Clin Exp Neuropsychol; 2017 Mar; 39(2):142-162. PubMed ID: 27686164
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cognitive and cortical thinning patterns of subjective cognitive decline in patients with and without Parkinson's disease.
    Hong JY; Yun HJ; Sunwoo MK; Ham JH; Lee JM; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2014 Sep; 20(9):999-1003. PubMed ID: 25001316
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mindfulness based intervention in Parkinson's disease leads to structural brain changes on MRI: a randomized controlled longitudinal trial.
    Pickut BA; Van Hecke W; Kerckhofs E; Mariën P; Vanneste S; Cras P; Parizel PM
    Clin Neurol Neurosurg; 2013 Dec; 115(12):2419-25. PubMed ID: 24184066
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel bedside task to tap inhibitory dysfunction and fronto-striatal atrophy in Parkinson's disease.
    O'Callaghan C; Naismith SL; Shine JM; Bertoux M; Lewis SJ; Hornberger M
    Parkinsonism Relat Disord; 2013 Sep; 19(9):827-30. PubMed ID: 23680420
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Topography of cortical thinning associated with white matter hyperintensities in Parkinson's disease.
    Ham JH; Yun HJ; Sunwoo MK; Hong JY; Lee JM; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2015 Apr; 21(4):372-7. PubMed ID: 25697488
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pattern of brain tissue loss associated with freezing of gait in Parkinson disease.
    Kostic VS; Agosta F; Pievani M; Stefanova E; Jecmenica-Lukic M; Scarale A; Spica V; Filippi M
    Neurology; 2012 Feb; 78(6):409-16. PubMed ID: 22282641
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Non-demented Parkinson's disease patients with apathy show decreased grey matter volume in key executive and reward-related nodes.
    Martinez-Horta S; Sampedro F; Pagonabarraga J; Fernandez-Bobadilla R; Marin-Lahoz J; Riba J; Kulisevsky J
    Brain Imaging Behav; 2017 Oct; 11(5):1334-1342. PubMed ID: 27730477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson's disease: results from a randomized trial.
    Witt K; Granert O; Daniels C; Volkmann J; Falk D; van Eimeren T; Deuschl G
    Brain; 2013 Jul; 136(Pt 7):2109-19. PubMed ID: 23801735
    [TBL] [Abstract][Full Text] [Related]  

  • 60. White matter abnormalities in Parkinson's disease patients with glucocerebrosidase gene mutations.
    Agosta F; Kostic VS; Davidovic K; Kresojević N; Sarro L; Svetel M; Stanković I; Comi G; Klein C; Filippi M
    Mov Disord; 2013 Jun; 28(6):772-8. PubMed ID: 23418083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.